Skip navigation

Navigate Regulatory Hurdles and Leverage Medical Utility, Safety, and Efficacy Data to Advance Clinical Research

November 30-December 1, 2017
  • Denver, CO

CBI's BioPharma Forum on Cannabis-Based Therapies is designed to help the medical and advocacy communities come together to design evidence-based communication strategies to arm the industry with the tools it needs to design a streamlined cross-industry approach to therapy development. Dive into scientific development challenges, legal hurdles, improving patient access and outcomes and examine the state of disorders and pathologies with potential cannabis-based treatments.

Leverage Cannabis Research Advancements as an Evolving Field in the Pharmaceutical Industry:

  • Explore cannabis based therapies unique applications in
    mitigating medical ailments and side effects
  • Discuss best practices in establishing
    clinical trial and research standards
  • Gain strategies for evaluating and
    measuring source quality and chemistry
  • Discuss the phyto-cannabinoid system and promising
    developments in utilizing CB receptors to achieve novel results
  • Capture up to date legal strategies for clinical trials
  • Hear up to date changes to the legal outlook for new
    cannapharma products
  • Collaborate on cross industry communication strategies to
    gain legislative buy in
  • Assess the role of the endocannabinoid system in combating PTSD,
    Epilepsy, Sturge Weber Syndrome and other debilitating conditions

NEW FOR 2017 | EXCLUSIVE ON-SITE FACILITY TOUR!

BioPharma Forum on Cannabis-Based Therapies

Navigate Regulatory Hurdles and Leverage Medical Utility, Safety, and Efficacy Data to Advance Clinical Research

CBI's BioPharma Forum on Cannabis-Based Therapies is designed to help the medical and advocacy communities come together to design evidence-based communication strategies to arm the industry with the tools it needs to design a streamlined cross-industry approach to therapy development. Dive into scientific development challenges, legal hurdles, improving patient access and outcomes and examine the state of disorders and pathologies with potential cannabis-based treatments.

Leverage Cannabis Research Advancements as an Evolving Field in the Pharmaceutical Industry:

  • Explore cannabis based therapies unique applications in
    mitigating medical ailments and side effects
  • Discuss best practices in establishing
    clinical trial and research standards
  • Gain strategies for evaluating and
    measuring source quality and chemistry
  • Discuss the phyto-cannabinoid system and promising
    developments in utilizing CB receptors to achieve novel results
  • Capture up to date legal strategies for clinical trials
  • Hear up to date changes to the legal outlook for new
    cannapharma products
  • Collaborate on cross industry communication strategies to
    gain legislative buy in
  • Assess the role of the endocannabinoid system in combating PTSD,
    Epilepsy, Sturge Weber Syndrome and other debilitating conditions

NEW FOR 2017 | EXCLUSIVE ON-SITE FACILITY TOUR!